# Enliven Therapeutics, Inc. — Form D

Enliven Therapeutics, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-03. The offering totals $90.0M, of which $90.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-04-03
- Form: D
- Accession: 0002017897-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $90.0M
- Amount sold: $90.0M
- Investors: 20
- Date of first sale: 2024-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509579

## Issuer

- Name: Enliven Therapeutics, Inc.
- CIK: 0001672619
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 6200 LOOKOUT ROAD, BOULDER, CO, 80301
- Phone: 720-647-8519

## Officers, directors & promoters (30)

_Showing 25 of 30 people._

| Name | Role | Location |
| --- | --- | --- |
| Rahul P Ballal | Director | Boulder, CO |
| Jake P Bauer | Director | Boulder, CO |
| Mika P Derynck | Director | Boulder, CO |
| Rishi P Gupta | Director | Boulder, CO |
| Richard P Heyman | Director | Boulder, CO |
| Samuel Kintz | Director | Boulder, CO |
| Joseph P Lyssikatos | Director | Boulder, CO |
| Andrew P Phillips | Director | Boulder, CO |
| Helen P Collins | Executive Officer | Boulder, CO |
| Benjamin P Hohl | Executive Officer | Boulder, CO |
| Samuel Kintz | Executive Officer | Boulder, CO |
| Joseph P Lyssikatos | Executive Officer | Boulder, CO |
| Anish P Patel | Executive Officer | Boulder, CO |
| Rahul Ballal | Director | Boston, MA |
| Rahul Ballal | Executive Officer | Boston, MA |
| David G Bonita | Director | CAMBRIDGE, MA |
| Christoph M Adams | Director | CAMBRIDGE, MA |
| Christoph M Adams | Executive Officer | CAMBRIDGE, MA |
| Barbara G Dalton | Director | CAMBRIDGE, MA |
| James G McArthur | Director | CAMBRIDGE, MA |
| James G McArthur | Executive Officer | CAMBRIDGE, MA |
| David G Mott | Director | CAMBRIDGE, MA |
| Carl G Goldfischer | Director | CAMBRIDGE, MA |
| Mark G Chin | Director | CAMBRIDGE, MA |
| Mette Kirstine Agger | Director | CAMBRIDGE, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-03-29](https://search.stillhousedata.com/formd/0001672619-19-000001) | D | $63.0M | $44.1M |
| [2016-04-21](https://search.stillhousedata.com/formd/0001672619-16-000001) | D | $31.0M | $6.0M |

## More

- [CIK 1672619 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1672619&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002017897-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.